Showing results (581-590 of 1,995) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|March 25, 2004
Headache with focal neurological signs or symptoms: a complicated differential diagnosisJean Schoenen, Peter S Sándor
The Lancet. Neurology|January 25, 2005
The neuro-ophthalmology of multiple sclerosisElliot M Frohman, Teresa C Frohman, David S Zee, et al.
The Lancet. Neurology|December 23, 2021
Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trialAlberto C S Costa, Ana C Brandão, Richard Boada, et al.
The Lancet. Neurology|December 23, 2021
Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal studyYves Dauvilliers, Isabelle Arnulf, Nancy Foldvary-Schaefer, et al.
The Lancet. Neurology|December 23, 2021
The neuropsychiatry of Parkinson's disease: advances and challengesDaniel Weintraub, Dag Aarsland, Kallol Ray Chaudhuri, et al.
The Lancet. Neurology|September 17, 2022
Sleep function: an evolutionary perspectiveJerome M Siegel
The Lancet. Neurology|November 20, 2021
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trialJordi Diaz-Manera, Priya S Kishnani, Hani Kushlaf, et al.
The Lancet. Neurology|November 20, 2021
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trialBenedikt Schoser, Mark Roberts, Barry J Byrne, et al.
The Lancet. Neurology|September 30, 2022
Diagnosis and classification of optic neuritisAxel Petzold, Clare L Fraser, Mathias Abegg, et al.
The Lancet. Neurology|October 10, 2022
Ageing and multiple sclerosisJennifer S Graves, Kristen M Krysko, Le H Hua, et al.
Pageof 200